United Therapeutics chair, CEO Martine Rothblatt reports $4.61 million UTHR share disposal

Rothblatt exercised stock options for 9,500 shares at $117.76 on Sept. 25, 2026, then a trust sold 9,500 shares the same day at $470.5565 to $478.9522. Trust holdings fell to 324,443 shares.